IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Tatva Chintan Pharma Chem IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 500.00 Cr. The company is based in Bharuch and caters to Chemical - Speciality sector. ICICI Securities , Jm Financial are the merchant bankers of Tatva Chintan Pharma Chem IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 31st May 2021.
Tatva Chintan Pharma Chem IPO posted revenues of ₹ 300.36 Cr. and PAT of ₹ 52.26 Cr. in FY25 on annualised basis.
Revenue:
₹ 300.36 Cr.
EBITDA Margin:
11.42
% 
Net Worth: ₹ 165.96 Cr.
Market Capitalisation:
[●]
P/E:
45.95 times
P/BV: [●]
EV/EBITDA: 2.09 times
Financial results of Tatva Chintan Pharma Chem IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY21 | FY20 | FY19 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 314.80 | 248.94 | 187.50 | ||
| Net Worth | 165.96 | 117.69 | 79.70 | ||
| Total Debt | 76.06 | 79.20 | 71.43 | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
300.36 | 263.24 | 206.31 | ||
EBITDA
EBITDA on annualised basis |
34.30 | 56.34 | 71.64 | ||
PAT
PAT on annualised basis |
52.26 | 37.79 | 20.54 | ||
Tatva Chintan Pharma Chem IPO PAT Margin is 17.40 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Tatva Chintan Pharma Chem IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY21 | FY20 | FY19 |
|---|---|---|---|
| EBITDA Margin (%) | 11.42 | 21.40 | 34.72 |
| PAT Margin (%) | 17.40 | 14.36 | 9.96 |
| EPS (₹) | 26.02 | 18.81 | 10.23 |
| ROE (%) | 31.49 | 32.11 | 25.77 |
| ROCE (%) | [●] | [●] | [●] |
| ROA (%) | 16.60 | 15.18 | 10.95 |
| Debt to Equity | 0.46 | 0.67 | 0.90 |
The market Capitalisation of Tatva Chintan Pharma Chem IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Tatva Chintan Pharma Chem IPO prospectus highlights an Return on Equity (ROE) of 31.49 % , Return on Assets (ROA) of 16.60 %, and an EBITDA Margin of 11.42 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Tatva Chintan Pharma Chem IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Tatva Chintan Pharma Chem IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Tatva Chintan Pharma Chem IPO has a Price-to-Earnings (PE) ratio of 45.95 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Tatva Chintan Pharma Chem IPO reported revenue of ₹ 306.29 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Tatva Chintan Pharma Chem IPO provide insights into sales growth, market demand, and business scalability.
Tatva Chintan Pharma Chem recorded an EBITDA of ₹ 34.30 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Tatva Chintan Pharma Chem Profit After Tax (PAT) is ₹ 52.26 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 300.36 Cr.
EBITDA Margin:
11.42
%
Net Worth: ₹ 165.96 Cr.
Market Capitalisation:
[●]
P/E:
45.95 times
P/BV: [●]
EV/EBITDA:
[●]
Tatva Chintan Pharma Chem operates in Chemical - Speciality and Specialty Chemicals Manufacturing. The Issue is listed on BSE,NSE in Jul, 2021. Tatva Chintan Pharma Chem IPO size was 500.00 with Issue price of 1083.00 .
Merchant Banker(s) of Tatva Chintan Pharma Chem IPO: ICICI Securities Limited , Jm Financial Limited
Tatva Chintan Pharma Chem IPO subscription was 180.36 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Tatva Chintan Pharma Chem IPO listed at a listing price of 2310.25 against the offer price of 1083.00.
The current market price of Tatva Chintan Pharma Chem is 1000.35.
Why Us?
